Medrio provides cloud-based eClinical solutions including EDC,eConsent,and ePRO,with a focus on rapid study startup and cost efficiency for early-phase and mid-size trials. Their platform is known for DIY study build capabilities and per-study pricing that appeals to emerging biotechs.
Vendor description
Best suited for emerging biotech sponsors running Phase I-II trials who need fast,cost-effective eClinical data capture.
Studies needing electronic data capture and trial workflow tools
- Self-service study builder with no programming required
- Per-study pricing model attractive to early-stage biotechs
- Integrated EDC,eConsent,and ePRO in one platform
- Fast study startup ? days rather than weeks
- Less suited to large global Phase III programmes
- Limited randomisation and supply chain management
- Smaller ecosystem of integrations compared to Medidata or Veeva
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Review snapshot
Medrios public employee feedback is mostly positive. Reviews commonly highlight strong people,decent pay,and good work-life balance,while negatives focus on leadership clarity and the growing pains of a smaller company. The overall picture is of a healthier-than-average culture,with strategy execution being the main question mark.
Good people - decent pay - work-life balance - supportive culture
Leadership clarity - small-company growing pains - uneven direction
Positive-leaning
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | Mid-market EDC vendor |
| Customer segment | mixed |
| Study phases | Phase I, Phase II |
| Trial scale | Global platform deployments |
| Therapeutic areas | Generalist |
| Last reviewed | 2026-03-28 |
Related vendors
Editorial ranking
See how Medrio compares - best Technology vendors for clinical trials.